Apollon Formularies to join US OTC Market and migrate to larger exchange
LONDON, UK: Apollon Formularies plc (AQSE: APOL), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, is advancing an application to join the OTCQB Market (“OTCQB”) in the United States. Apollon’s Ordinary Shares will continue to trade…